Senior Director, Product Management Team Lead (Late Phase & Commercialization) – Foster City at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Significant experience managing late-phase biopharma programs
Deep expertise in late phase, including launch planning and early commercialization product milestones
Expertise as a subject matter expert (SME) for late-phase product management across the Product & Project Management group
Ability to lead a team of product and project management professionals supporting small molecule and biologics drug candidates across development and commercial stages
Experience supporting programs across all biopharma lifecycle phases, with specialized knowledge for transitions from early development through commercialization

Responsibilities

Lead a team of product managers (PMs) to support PDM Product Strategy Leads and Product Teams, including identifying and sharing best practices across Product Strategy Teams
Serve as SME on late-phase PM, drawing upon deep knowledge of late phase, including launch planning and early commercialization product milestones
Use and provide feedback on templated tools and processes for the PDM Team System (e.g., tools for capturing a product’s strategy on a single page)
Work in partnership with PDM Product Strategy Leads to develop, gain approval for, and execute product strategy, including key milestones, budgeting, and resource allocation
Support PDM Operations Management’s implementation and iteration of G.Plan (Planisware) and G.Plan product templates, including supporting the flow of accurate data
Oversee Director-level PMs leading non-product strategic initiatives contributing to broader organizational priorities
Report to the Executive Director of Product & Project Management within the Pharmaceutical Development and Manufacturing (PDM) organization

Skills

Product Management

Project Management

Team Leadership

Pharmaceutical Development

Manufacturing

Commercialization

Late Phase Development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free